Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Scholarships drive student success in AI and data science

Students offered scholarships to study artificial intelligence (AI) and data science at Teesside University have shared how the support is helping them to progress in their careers.Teesside University launched 20 scholarships last year to support students from under-represented backgrounds to study postgraduate degrees in AI and data science. Teesside was one of 30 UK institutions chosen by the Office for Students (OfS) to receive a share of £8.1m funding from the Department for Science, Innovation and Technology (DSIT) and Office for Artificial Intelligence (OAI) to tackle digital

Munters Annual and Sustainability Report 2023

Munters Group AB´s (NASDAQ:MTRS) Annual and Sustainability Report 2023 has been published on www.munters.com in English and Swedish. The report can be downloaded here: https://www.munters.com/en/investor-relations/financial-reports/. The Swedish Annual and Sustainability Report is also available on the website in European Single Electronic Format (ESEF). The report has also been printed in a limited edition and can be ordered from investorrelations@munters.com. This information is information that Munters Group AB is obliged to make public pursuant to the Securities Markets Act.The

Prolight Diagnostics CEO to BioStock: "We deliver on all goals”

Prolight Diagnostics' year-end report for 2023 shows that the company met all the goals for the year. The company's point-of-care analysis system has shown proof-of-performance for measurement of troponin in whole blood. In addition, the company has formed a Clinical Advisory Board and established an R&D manufacturing line for the upcoming pilot production. The goal for 2024 is to complete the development of the system for clinical validation.Read the full article at biostock.se : https://www.biostock.se/en/2024/02/prolight-diagnostics-ceo-we-deliver-on-all-

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 43 – 23 FEBRUARY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation

Mölndal, Sweden – February 23, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its third quarter 2023/24 results on February 29, 2024 at 14:00 CEST.Integrum’s CEO Rickard Brånemark will present the report together with CFO Jörgen Svanström and US President Jeffrey Zanni in a webcast. The presentation will be held in English. Time: Thursday, February 29, 2024 at 14:00 CEST. Location: Webcast (see link below). The report will be available at https://integrum.se/investor-relations/financial-reports-calendar/ The webcast and

Flowscape wins contract with large Finnish company

A large Finnish company chooses Flowscapes smart office solution for its offices in Europe. The order value of the initial three offices amounts to EUR 147,000 (SEK 1,650,000) in the first year and there after EUR 64,000 (SEK 745,000) annually recurring."We are happy and proud that this customer decided for Flowscape's smart office solution for their offices. The customer already had an existing solution from another supplier that they now chose to replace with Flowscape’s solution. The customer has more than 10 offices in Europe and the orders now received are for three offices. We have

Invitation to webcast – presentation of fourth quarter 2023 result

Solstad Offshore welcomes to presentation of its 4Q 2023 report, Friday, March 1st, 2024, at 09:00 am. The presentation will be held by Lars Peder Solstad and Kjetil Ramstad. 4Q 2023 report will be released Thursday, February 29th, 2024, and made available on www.solstad.com and www.newsweb.no. Solstad 4Q 2023 presentation: Date: Friday, March 1st, 2024 Time: 09:00 a.m. CEST Format: Live webcast Language: English Link: https://channel.royalcast.com/landingpage/hegnarmedia/20240301_2/ A recorded version will be made available at https://www.solstad.com Skudeneshavn,

Axfood publishes Annual and Sustainability Report 2023

Axfood’s Annual and Sustainability Report 2023 has been published and is now available on the Group’s website.– In changing times, another successful year for Axfood is summarised with high growth, increased market share and major strides towards increased competitiveness through investments in digitalisation, automation and the customer offering. Our business model remains strong despite significant changes in market dynamics and it is clear that more people have come to appreciate our concepts and offerings. This provides us with excellent conditions for continued long-term, profitable

Lundbeck announces changes to Executive Management

Lundbeck announces changes to Executive Management Valby, Denmark, February 23, 2024 - H. Lundbeck A/S (Lundbeck) today announced the following changes in the Executive Management team. Jacob Tolstrup, Executive Vice President, Commercial Operations will leave Lundbeck no later than March 1, 2024. Jacob Tolstrup joined Lundbeck in 1999 and has held various management positions across the company, becoming a member of Lundbeck’s Executive Management team in 2012. “We would like to express gratitude to Jacob for his long-standing commitment to Lundbeck. Jacob has been a valuable

Cereno Scientific releases Insights Videos Season 3 Episode 5 with Dr. Raymond Benza, System Director of Pulmonary Hypertension, Mount Sinai Health System

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episode 5 of Season 3 in the Insights Video Series has been released. In the video, recorded at the Pulmonary Vascular Research Institute (PVRI) Annual Congress 2024, Dr. Raymond Benza, System Director of Pulmonary Hypertension at Mount Sinai Icahn School of Medicine, New York City, Principal Investigator of the Phase II study of CS1, and member of Cereno’s Scientific Advisory Board, talks about what “Compassionate Use” is and how the

Solwers Plc issues 58,071 new shares

Solwers Plc Company Release 23.02.2024 at 09.45 a.m. EEST Solwers Plc announced on 29 January 2024 that it is expanding the range of services offered to the industry by acquiring the entire share capital of the Swedish Relitor Engineering AB. Part of the purchase price was agreed to be paid with Solwers Plc’s shares. The total number of shares directed to the sellers is 58,071 shares. The 58,071 new shares have today been registered in the trade register maintained by the Finnish Patent and Registration Office and the total number of shares issued by Solwers Plc increases from 9,946,

Tobii’s intended rights issue fully covered by subscription and guarantee undertakings

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN TOBII AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW IN THIS DOCUMENT.Tobii AB (publ) today announces that its intended rights issue of approximately SEK 300 million is fully covered by subscription and guarantee undertakings.

The subscription period in Curasight’s rights issue begins today

Copenhagen, Denmark, 23 February 2024 - Today is the first day of the subscription period in Curasight A/S’s ("Curasight" or the “Company" – TICKER: CURAS) new issue of shares with preferential rights for the Company's existing shareholders of up to DKK 51.2 million before transaction costs (the “Rights Issue"), which was resolved by the Board of Directors on 13 February 2024.Summary of the Rights Issue · Each existing share in the Company, as of the record date on 22 February 2024, entitles the holder to one (1) subscription right. Seven (7) subscription rights entitle the holder to

Ellos Group AB (publ) interim report January - December 2023

Press release, Borås, 23 February 2024   The interim report for Ellos Group AB (publ) is published today. THE FOURTH QUARTER 2023 • Net sales decreased by 4.7 % to SEK 993.6 (1 042.2) million. Organically, net sales decreased by 4.5 %. • The gross margin increased to 51.8 (49.3) %. • Adjusted EBITA increased to SEK 73.5 (26.5) million. The adjusted EBITA margin increased to 7.4 (2.5) %. • The operating profit/loss increased to SEK 42.3 (-11.6) million. The operating margin increased to 4.3 (-1.1) %. • Cash flow from operating activities amounted to SEK 157.2 (68.6)

Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO

Press Release – Oslo, Norway, February 23, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that that the international multicenter Phase III clinical study of Cevira[®] (APL-1702), the non-surgical treatment in development for cervical high-grade squamous intraepithelial lesions (HSIL), has been selected for late breaking oral presentation at the 2024 SGO Annual Meeting on Women’s Cancer of the Society of Gynecologic Oncology, to be held March 16-18 in San Diego, CA, USA:· Oral presentation:

Heliospectra (publ) Publish the Year-End Report for 2023

(GOTHENBURG, Sweden, Feb 23, 2024, at 08:30 CET)– Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Year-End Report for 2023.Full report is enclosed to this press release and is also uploaded at https://heliospectra.com/investor-relations/financial-reports-documents/reports/. SUMMARY OF REPORT Sales and financial performance October – December 2023 · Order intake during the period amounted to SEK 9,377 (12,677) thousand. · Net sales during the period amounted to SEK 9,908 (9,998) thousand.

Wyld Networks sign an agreement with Staw Agricultura to deploy Wyld Connect for strawberry production in Brazil

Brazilian strawberry producer, Staw Agricultura, will deploy Wyld Network’s sensor to satellite technology to collect soil moisture data from strawberry farms in the south-east of Brazil.The global fresh strawberry market size was valued at US$ 19.1 billion in 2022 and is expected to expand at a CAGR of 6.03% between 2024 and 2031, reaching US$ 27.2 billion by 2031.   Central to this rapid growth is the Brazil strawberry production market exemplified by Staw Agricultura based in the city of Pinhalão in the Brazilian State of Parana. Staw Agricultura utilise new technologies to produce

Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January – 31 December 2023

Cline Scientific AB (publ) ("Cline" or the "Company") issues the following bokslutskommuniké for 2023.July - December 2023  · Net sales amounted to SEK 0 (0). ·  Operating profit amounted to SEK 240,145 (237,140). · Profit per average number of shares after tax amounted to 0.01 (0.01) January - December 2023 · Net sales amounted to SEK 0 (0). ·  Operating profit amounted to SEK -3,108,861 (-2,317,061) · Profit per average number of shares after tax amounted to -0.10 (-0.15) The report is published at www.clinescientific.com/financial-reports For more

Valmet’s social responsibility program continues with several area-specific projects around the world

Valmet Oyj’s press release on February 23[rd], 2024 at 9:30 a.m. EETValmet expanded its global social responsibility program with several area-specific local projects promoting science, nature and equal opportunities in 2022. After a year of successful implementation, the program now continues through six local projects. Social responsibility program is part of Valmet’s sustainability agenda implementation. Some of the projects are selected by employee voting, increasing involvement and internal engagement.  In 2024, the program continues with the following projects:  In Asia

Clinical Laserthermia Systems AB publishes Year-end report January – December 2023

Summary of the interim report (relates to the Group) Full year (01/01/2023–12/31/2023) · Net sales totaled SEK 8,273,000 (SEK 6,268,000). · Operating profit/loss totaled SEK –65,933,000 (SEK -67,442,000) · Profit/loss after financial items totaled SEK –80,875,000 (SEK -71,265,000). · Basic and diluted earnings per share totaled SEK -0.12 (SEK -0.85). · The equity ratio at December 31, 2023, was 75,4% (18,6%). The fourth quarter (10/01/2023 – 12/31/2023) · Net sales totaled SEK 4,456,000 (SEK 4,295,000). · Operating profit/loss totaled SEK –20,408,000 (SEK -18,

The subscription period in Elicera Therapeutics’ rights issue of units starts today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.   Today, February 23, 2024, the subscription period begins in Elicera Therapeutics AB’s (publ) (“Elicera” or the “Company”) rights issue of units consisting of

JM’s subsidiary AB Borätt acquiring building rights for residential development in Sollentuna

AB Borätt has acquired building rights for the development of approximately 220 residential units located in Sollentuna just north of Stockholm. The acquisition amounts to approximately SEK 150m including a paid development contribution. Occupancy and first payment will take place in the first quarter of 2024. Final payment will take place in the second quarter of 2026.The acquisition will be reported within the JM Residential Stockholm business segment in the first quarter of 2024.   The property has a detailed plan that has gained legal force and is judged to allow the development

ARTE COLLECTUM I AB (PUBL) FINANCIAL STATEMENT 2023

PRESS RELEASE23 February 2024, at 08:00 – Stockholm.Arte Collectum I AB (publ)www.artecollectum.comArte Collectum I AB (publ) (the “Fund”) issues a year-end report regarding the period 1 January 2023 to 31 December 2023. · The operating profit amounted to TEUR -695. · The profit after tax amounted to TEUR -365. · The investments in art amounted to TEUR 7,021. · The value of the portfolio amounted to TEUR 15,157 as per 31 December 2023. · The net asset value (NAV) per unit in the Fund amounted to EUR 9,403 corresponding to 94.03 per cent, with a theoretical NAV which

There are no items matching the current filter
There are no more items matching the current filter
Back to top